Health News

Rx Treats the Gut, but Upsets the Blood
Patients with ulcerative colitis can be treated effectively with a class of medications called thiopurines . But taking these medications over a long period of time can have some negative effects.
Gut Feeling About Cancer
In patients with celiac disease, the immune system attacks the patient's own body and causes damage to the lining of the gut. The disease has been linked to a higher risk of lymphoma, a type of blood cancer.
Industrial Pollution Not Just Dirty
Benzene is a chemical that’s used in the making of all sorts of products, ranging from plastics to detergents. It’s also a chemical that’s been linked to blood cancers.
These Cells Can Stem Blood Cancer
Being diagnosed with leukemia or lymphoma can be a major life change for patients. With new advances in medicine, they may have some respite. 
Non-Hodgkin Rx Trial Halted
A new medication that was thought to hold promise for non-Hodgkin lymphoma has been stopped. Pfizer announced it has halted its trial of the investigational compound inotuzumab ozogamicin.
Back to Hospital after Stem Cell Transplant
Stem cell transplants can – and do – save the lives of very sick kids. New research has discovered that the transplant is often just the start of hospital stays for these young patients.
No Need to Fear Lupus Medications
Fear that the treatment for one condition might cause another condition, like cancer, could prevent people from taking needed medications. But should this be a concern for lupus patients?
Battling Fatigue Decades Later
Being tired after any type of cancer therapy is to be expected. Some survivors of childhood cancer, though, can still be battling fatigue many years later.
Closing In on a Cure
Someone diagnosed with any type of leukemia in the early 1960s had about a 14 percent chance of being alive five years later. Today, those chances are vastly greater. 
Cancer Rx Granted Accelerated FDA Approval Path
The US Food and Drug Administration has given ibrutinib an accelerated pathway to approval. Ibrutinib is an investigational drug designed to treat two lymphomas.